美股A股
StockGist
Back
6-K2026-05-07· qwen-plus

SSYS · Stratasys Ltd.

0001628280-26-031774

SEC filing

Summary

Stratasys reported a $23.8 million net loss for Q1 2026, with revenues down 2.5% year-over-year to $132.7 million, driven by macroeconomic pressure extending sales cycles and tariff-related margin compression, while also disclosing a $120M PIPE investment from Fortissimo and completion of a strategic restructuring plan.

Key takeaways

Full analysis

Stratasys’ Q1 2026 results reflect intensifying macroeconomic headwinds: revenue declined 2.5% YoY to $132.7M, driven by a $5.0M (5.4%) drop in products revenue—primarily attributed to extended sales cycles stemming from constrained customer capital expenditure budgets. Services revenue rose 4.0% to $43.9M, led by $1.6M higher Stratasys Direct Manufacturing (SDM) revenue, partially offsetting product weakness. Gross margin contracted 260 bps to 41.7%, with $1.8M in U.S. tariff charges directly eroding product gross margin (down to 47.5% from 49.6%) and $0.6M impacting services. Operating expenses surged 12.7% to $81.9M, fueled by an $8.5M increase in litigation-related legal expenses and $3.1M in unfavorable currency impacts—outpacing the 1.9% R&D increase and contributing to a $14.1M deterioration in operating loss. The company completed its strategic restructuring—including a ~15% headcount reduction—by Q2 2024, targeting $40M in annualized savings and an 8% EBITDA margin; however, Q1 2026 adjusted EBITDA fell to $2.0M from $8.2M YoY, indicating ongoing margin pressure despite cost actions. The $120M PIPE from Fortissimo (April 2025) strengthened the balance sheet—cash and equivalents stood at $71.8M as of March 31, 2026—and brought governance changes, including Yuval Cohen’s board appointment and Fortissimo’s 14.9% ownership stake. Management explicitly links performance to external factors: persistent tariffs, elevated interest rates, energy price volatility, and geopolitical risk—including potential disruption to Israeli-based operations—and offers no forward guidance, only conditional optimism that improvement would follow macro stabilization. With no share repurchases in FY2025 or Q1 2026 and $50M authorization still unused, capital return remains suspended pending improved execution and macro conditions.